Hjem › Akut bifænotypisk leukæmi › Hawaii › Honolulu
Akut bifænotypisk leukæmi kliniske forsøg i Honolulu, HI
3 studier for Akut bifænotypisk leukæmi søger deltagere på steder i og omkring Honolulu (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RekruttererFase 2
- Kapiolani Medical Center for Women and Children, Honolulu
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekruttererFase 3
- Kapiolani Medical Center for Women and Children, Honolulu
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Kapiolani Medical Center for Women and Children, Honolulu
Akut bifænotypisk leukæmi forsøg i andre byer
- Seattle, WA15 studier
- Houston, TX11 studier
- New York City, NY10 studier
- Atlanta, GA9 studier
- Durham, NC8 studier
- Memphis, TN7 studier
- Chicago, IL7 studier
- Charlotte, NC6 studier
- Aurora, CO6 studier
- Baldwin Park, CA6 studier
- Portland, OR6 studier
- Los Angeles, CA6 studier
Andre studier i Honolulu
- Kræft (alle typer)13 studier
- Overvægt13 studier
- Brystkræft12 studier
- Overvægt11 studier
- Ikke-småcellet lungecancer10 studier
- Lungecancer8 studier
- Akut myeloid leukæmi7 studier
- Type 2-diabetes7 studier
- Ægstockræft7 studier
- Bugspytkirtelkræft7 studier
- Neuroblastom6 studier
- Prostatakræft5 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.